Relationship of Hypoalbuminemia in Colistin-Induced Acute Kidney Injury (AKI) among Adult Intensive Care Patients: Hypoalbuminemia in Colistin-Induced Acute Kidney Injury

Sughandh Umer Memon; Saima Samad; Nazish Misbah; Saima Muzaffar; Sadia Ishaque; Shumaila Kamran

doi:10.54393/pjhs.v6i1.2286

Authors

Sughandh Umer Memon Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi,
Saima Samad Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi,
Nazish Misbah Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi,
Saima Muzaffar Dr. Ziauddin Hospital Clifton, Karachi, Pakistan
Sadia Ishaque Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi, Pakistan
Shumaila Kamran Dr. Ruth K. M. Pfau Civil Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i1.2286

Keywords:

Acute Kidney Injury, Colistin Therapy, Intensive Care Unit, Hypoalbuminemia

Abstract

Acute kidney injury incidence ranges from 30-60% among critically ill patients and stands as the primary death cause within this population. A serious concern is a global rise in major drug-resistant-gram-negative organisms among hospital-acquired infections. Objectives: To determine the incidence of colistin-induced acute kidney injury in intensive care patients receiving colistin therapy and to investigate its relationship with albumin levels. Methods: It was a follow-up prospective cohort study executed at Shaheed Mohtarma Benazir Bhutto Institute of Trauma Pakistan in an adult intensive care unit over 6 months. The study end-point was an injury in intensive care injury at the end of colistin therapy. A total of 250 patients were studied. The median age of patients was 40 (IQR=22-48) years with an age range of 18-70 years. The majority of patients were male (75.2%). Median colistin dosage was 4 (IQR=3.5-4.5) MIU. In univariate analysis, the risk of developing injury in intensive care was significantly increased with increased age, use of nephrotoxic drugs, and increasing colistin dosage whereas injury in intensive care risk was decreased with increasing albumin levels. In a multivariable model, only colistin dosage was found to be significantly associated with increasing injury in intensive care risk with increasing colistin dosage. Conclusions: It was concluded that the present study analyzed a higher burden of acute kidney injury incidence following colistin therapy. Albumin levels were not found to be linked to acute kidney injury incidence in the multivariable model. Acute kidney injury incidence was significantly related to increasing colistin dosage.

References

Hoste EA, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global Epidemiology and Outcomes of Acute Kidney Injury. Nature Reviews Nephrology. 2018 Oct; 14(10): 607-25. doi: 10.1038/s41581-018-0052-0.

Ying J, Wang J, Ying Z, Ran X, Zeng X, Chen D, et al. Exploring the Relationship Between Post-Contrast Acute Kidney Injury and Different Baseline Creatinine Standards: A Retrospective Cohort Study. Frontiers in Endocrinology. 2023 Jan; 13: 1042312. doi: 10.3389/fendo.2022.1042312.

Wollein Waldetoft K, Sundius S, Kuske R, Brown SP. Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance Optimization. Mbio. 2023 Feb; 14(1): e01349-22. doi: 10.1128/mbio.01349-22.

Morris S and Cerceo E. Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting. Antibiotics. 2020 Apr; 9(4): 196. doi: 10.3390/antibiotics9040196.

Gameiro J, Fonseca JA, Outerelo C, Lopes JA. Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies. Journal of Clinical Medicine. 2020 Jun; 9(6): 1704. doi: 10.3390/jcm9061704.

Katip W, Oberdorfer P, Taruangsri P, Nampuan T. Risk Factors for Acute Kidney Injury in Patients Receiving Intravenous Colistin. Pharmaceutical Sciences. 2024 Jan; 30(2): 244-51. doi: 10.34172/PS.2023.31.

El-Sayed Ahmed MA, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB. Colistin and Its Role in the Era of Antibiotic Resistance: An Extended Review (2000–2019). Emerging Microbes and Infections. 2020 Jan; 9(1): 868-85. doi: 10.1080/22221751.2020.1754133.

Binsker U, Käsbohrer A, Hammerl JA. Global Colistin Use: A Review of the Emergence of Resistant Enterobacterales and the Impact On Their Genetic Basis. FEMS Microbiology Reviews. 2022 Jan; 46(1): fuab049. doi: 10.1093/femsre/fuab049.

Almutairy R, Aljrarri W, Noor A, Elsamadisi P, Shamas N, Qureshi M et al. Impact of Colistin Dosing On the Incidence of Nephrotoxicity in A Tertiary Care Hospital in Saudi Arabia. Antibiotics. 2020 Aug; 9(8): 4 85. doi: 10.3390/antibiotics9080485.

Mirjalili M, Mirzaei E, Vazin A. Pharmacological Agents for the Prevention of Colistin-Induced Nephrotoxicity. European Journal of Medical Research. 2022 May; 27(1): 64. doi: 10.1186/s40001-022-00689-w.

Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M. Molecular Mechanisms of Colistin-Induced Nephrotoxicity. Molecules. 2019 Feb; 24(3): 653. doi: 10.3390/molecules24030653.

Sangthawan P, Geater AF, Naorungroj S, Nikomrat P, Nwabor OF, Chusri S. Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin. Antibiotics. 2021 Dec; 11(1): 2. doi: 10.3390/antibiotics11010002.

Morales-Alvarez MC. Nephrotoxicity of Antimicrobials and Antibiotics. Advances in Chronic Kidney Disease. 2020 Jan; 27(1): 31-7. doi: 10.1053/j.ackd.2019.08.001.

Li N, Qiao H, Guo JF, Yang HY, Li XY, Li SL et al. Preoperative Hypoalbuminemia Was Associated with Acute Kidney Injury in High-Risk Patients Following Non-Cardiac Surgery: A Retrospective Cohort Study. BioMed Central Anesthesiology. 2019 Dec; 19: 1-1. doi: 10.1186/s12871-019-0842-3.

Zheng LJ, Jiang W, Pan L, Pan J. Reduced Serum Albumin as A Risk Factor for Poor Prognosis in Critically Ill Patients Receiving Renal Replacement Therapy. BioMed Central Nephrology. 2021 Dec; 22: 1-1. doi: 10.1186/s12882-021-02512-w.

Walther CP, Gutiérrez OM, Cushman M, Judd SE, Lang J, McClellan W et al. Serum Albumin Concentration and Risk of End-Stage Renal Disease: The Regards Study. Nephrology Dialysis Transplantation. 2018 Oct; 33(10): 1770-7. doi: 10.1093/ndt/gfx331.

Chen L, Wu X, Qin H, Zhu H. The PCT to Albumin Ratio Predicts Mortality in Patients with Acute Kidney Injury Caused by Abdominal Infection-Evoked Sepsis. Frontiers in Nutrition. 2021 Jun; 8: 584461. doi: 10.3389/fnut.2021.584461.

Deniz M and Alişik M. Risk Factors and Prognosis for the Development of Acute Kidney Injury in Patients Using Colistin in the Intensive Care Unit: A Retrospective Cohort Study. Medicine. 2024 Jan; 103(2): e36913. doi: 10.1097/MD.0000000000036913.

Arrayasillapatorn N, Promsen P, Kritmetapak K, Anunnatsiri S, Chotmongkol W, Anutrakulchai S. Colistin‐Induced Acute Kidney Injury and the Effect On Survival in Patients with Multidrug‐Resistant Gram‐Negative Infections: Significance of Drug Doses Adjusted to Ideal Body Weight. International Journal of Nephrology. 2021; 2021(1): 7795096. doi: 10.1155/2021/7795096.

Alotaibi FM, Alshehail BM, Al Jamea ZA, Joseph R, Alanazi AH, Alhamed NA et al. Incidence and Risk Factors of Colistin-Induced Nephrotoxicity Associated with the International Consensus Guidelines for the Optimal Use of the Polymyxins: A Retrospective Study in A Tertiary Care Hospital, Saudi Arabia. Antibiotics. 2022 Nov; 11(11): 1569. doi: 10.3390/antibiotics11111569.

Moghnieh R, Husni R, Helou M, Abdallah D, Sinno L, Jadayel M et al. The Prevalence and Risk Factors of Acute Kidney Injury during Colistin Therapy: A Retrospective Cohort Study from Lebanon. Antibiotics. 2023 Jul; 12(7): 1183. doi: 10.3390/antibiotics12071183.

Sun J, Su H, Lou Y, Wang M. Association Between Serum Albumin Level and All-Cause Mortality in Patients with Chronic Kidney Disease: A Retrospective Cohort Study. The American Journal of the Medical Sciences. 2021 Apr; 361(4): 451-60. doi: 10.1016/j.amjms.2020.07.020.

Shah S, Leonard AC, Harrison K, Meganathan K, Christianson AL, Thakar CV. Mortality and Recovery Associated with Kidney Failure Due to Acute Kidney Injury. Clinical Journal of the American Society of Nephrology. 2020 Jul; 15(7): 995-1006. doi: 10.2215/CJN.11200919.

Nagata K, Horino T, Hatakeyama Y, Matsumoto T, Terada Y, Okuhara Y. Effects of Transient Acute Kidney Injury, Persistent Acute Kidney Injury and Acute Kidney Disease on the Long‐Term Renal Prognosis After an Initial Acute Kidney Injury Event. Nephrology. 2021 Apr; 26(4): 312-8. doi: 10.1111/nep.13831.